Plain-English translation of NCT05933499 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This research trial is testing whether combined with —two medications that work in different ways—can help you lose weight more effectively than either medication alone. When people lose weight, they often lose not just fat, but also muscle and bone, which can cause problems. This study is designed to see if using both medications together helps you lose fat while keeping your muscle and bone strong.
Most weight-loss treatments cause people to lose muscle and bone along with fat, which can weaken the body and slow down metabolism. Researchers believe this new combination treatment might help you lose primarily fat while protecting the muscle and bone that keep you healthy and strong.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive one of three treatment combinations over 52 weeks (about one year): plus the new medication, plus a placebo (inactive pill), or the new medication plus a placebo. You'll receive the medications by injection and attend regular clinic visits for blood work, body composition measurements, and check-ins. Throughout the study, you'll also participate in a lifestyle program focused on healthy eating and physical activity to support your weight loss.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States